Partnering to Achieve Your Next Neuroscience Breakthrough
We share your vision. Like you, the neuroscience team at PPD is driven to find answers in this area of drug development. With unmet needs outweighing treatment solutions for many conditions affecting the central nervous system (CNS), every step forward can have a monumental impact on how neurological disorders are managed—forever reshaping the future for patients and caregivers for the better.
Armed with experience in novel treatment modalities and a broad range of indications, we can confidently guide you to your neuroscience breakthrough.
In the past five years, we have supported:
Ingenuity for the Evolving Neuroscience Clinical Trial Landscape
We continue to invest in solutions and teams that improve neuroscience study certainty and quality for our clients and patients.
Clinical Trial Simulator
Works to identify potential gaps in the program early on and guide the selection of design parameters, used for indications such as Alzheimer’s and Parkinson’s disease.
Dedicated Patient Enrollment Solution
Decentralized Clinical Trial Technology and Patient-Centric Solutions
Ease the burden on clinical trial participants and their caregivers with decentralized clinical trial (DCT) advancements, specifically for the neuroscience area of research.
These solutions include:
- Direct-to-patient models
- Remote eConsent
- Home health care services